Herd-specific custom vaccines
Through significant investments in a state-of-the-art production facility, diagnostic capabilities and the exciting ENABL® adjuvant platform, Huvepharma delivers custom vaccines to help veterinarians and producers address emerging as well as herd-specific disease challenges.
ENABL is a next generation adjuvant technology – featuring a lipid/polymer matrix – with benefits and performance like no other. In combination with ENABL, our proprietary PRRS vaccine manufacturing process broadens and enhances the immune response.
ENABL adjuvant technology allows for more efficient delivery of vaccines. A unique ability to deliver antigens makes it practical to use fewer inactivated virulence factors as antigens in smaller doses to reduce risks of adverse reactions in the animal.
Learn more about Huvepharma custom vaccines by calling 800-542-8916, emailing email@example.com or completing our contact form.